Optimization of inhaled therapies for tuberculosis: The role of macrophages and dendritic cells

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 86-92

  González Juarrero, Mercedes ^a   O'Sullivan, Mary P ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b ST JAMES S HOSPITAL   (Ireland)

Author keywords

Dendritic cell; Inhaled therapy; Macrophage; Tuberculosis

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; DNA VACCINE; MYCOBACTERIUM TUBERCULOSIS SECRETORY ANTIGEN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; CELL ACTIVATION; CELL DEATH; DENDRITIC CELL; DRUG DELIVERY SYSTEM; GRANULOMA; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

ADMINISTRATION, INHALATION; ANTITUBERCULAR AGENTS; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 79551481328     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.08.007     Document Type: Review

References (116)

1. B.C. Trapnell, and J.A. Whitsett GM-CSF regulates pulmonary surfactant homeostasis and alvoelar macrophage-mediated innate host defense Annu Rev Physiol 64 2002 775 802
2. J.S. Ferguson, and L.S. Schlesinger Pulmonary surfactant in innate immunity and the pathogenesis of tuberculosis Tuber Lung Dis 80 2000 173 184
3. Y. Shibata, P.Y. Berclaz, Z.C. Chroneos, M. Yoshida, J.A. Whitsett, and B.C. Trapnell GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1 Immunity 15 2001 557 567
4. J.B. Torrelles, A.K. Azad, L.N. Henning, T.K. Carlson, and L.S. Schlesinger Role of C-type lectins in mycobacterial infections Curr Drug Targets 9 2008 102 112
5. T. Bernier, T. Tschernig, R. Pabst, O. Macke, C. Steinmueller, and A. Emmendorffer Effects of macrophage-CSF on pulmonary-macrophage repopulation after bone marrow transplantation J Leukoc Biol 70 2001 39 45
6. B.J. Masten, G.K. Olson, D.F. Kusewitt, and M.F. Lipscomb Flt3 ligand preferentially increases the number of functionally active myeloid dendritic cells in the lungs of mice J Immunol 172 2004 4077 4083
7. M. Gonzalez-Juarrero, T.S. Shim, A. Kipnis, A.P. Junqueira-Kipnis, and I.M. Orme Dynamics of macrophage cell populations during murine pulmonary tuberculosis J Immunol 171 2003 3128 3135
8. K. Vermaelen, and R. Pauwels Pulmonary dendritic cells Am J Respir Crit Care Med 172 2005 530 551
9. C. Jakubzick, F. Tacke, J. Llodra, N. van Rooijen, and G.J. Randolph Modulation of dendritic cell trafficking to and from the airways J Immunol 176 2006 3578 3584
10. D.M. Higgins, J. Sanchez-Campillo, A.G. Rosas-Taraco, J.R. Higgins, E.J. Lee, and I.M. Orme Relative levels of M-CSFand GM-CSF influence the specific generation of macrophage populations during infection with Mycobacterium tuberculosis J Immunol 180 2008 4892 4900
11. P.A. Stumbles, J.W. Upham, and P.G. Holt Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract APMIS 111 2003 741 755
12. P. Muttil, C. Wang, and A.J. Hickey Inhaled drug delivery for tuberculosis therapy Pharm Res 26 2009 2401 2416
13. P. Muttil, J. Kaur, K. Kumar, A.B. Yadav, R. Sharma, and A. Misra Inhalable microparticles containing large payload of anti-tuberculosis drugs Eur J Pharm Sci 32 2007 140 150
14. The pathogenesis of tuberculosis v 2nd ed. 1951 Charles C. Thomas Springfield, Illinios
15. L.S. Schlesinger Role of mononuclear phagocytes in M. tuberculosis pathogenesis J Investig Med 44 1996 312 323
16. L.S. Schlesinger Entry of Mycobacterium tuberculosis into mononuclear phagocytes Curr Top Microbiol Immunol 215 1996 71 96
17. T.K. Carlson, J.B. Torrelles, K. Smith, T. Horlacher, R. Castelli, and P.H. Seeberger Critical role of amino acid position 343 of surfactant protein-D in the selective binding of glycolipids from mycobacterium tuberculosis Glycobiology 19 2009 1473 1484
18. J.S. Ferguson Surfactant protein D increases fusion of Mycobacterium tuberculosis-containing phagosomes with lysosomes in human macrophages Infect Immun 74 2006 7005 7009
19. J.S. Ferguson, D.R. Voelker, J.A. Ufnar, A.J. Dawson, and L.S. Schlesinger Surfactant protein d inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination J Immunol 168 2002 1309 1314
20. C.D. Gaynor, F.X. McCormack, D.R. Voelker, S.E. McGowan, and L.S. Schlesinger Pulmonary surfactant protein a mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages J Immunol 155 1995 5343 5351
21. L. Hall-Stoodley, G. Watts, J.E. Crowther, A. Balagopal, J.B. Torrelles, and J. Robison-Cox Mycobacterium tuberculosis binding to human surfactant proteins a and d, fibronectin, and small airway epithelial cells under shear conditions Infect Immun 74 2006 3587 3596
22. U. Schwab, K.H. Rohde, Z. Wang, P.R. Chess, R.H. Notter, and D.G. Russell Transcriptional responses of Mycobacterium tuberculosis to lung surfactant Microb Pathog 46 2009 185 193
23. Z. Wang, U. Schwab, E. Rhoades, P.R. Chess, D.G. Russell, and R.H. Notter Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function Tuberculosis (Edinb) 88 2008 178 186
24. J. Day, A. Friedman, and L.S. Schlesinger Modeling the immune rheostat of macrophages in the lung in response to infection Proc Natl Acad Sci U S A 106 2009 11246 11251
25. A.B. Yadav, R. Sharma, P. Muttil, A.K. Singh, R.K. Verma, and M. Mohan Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy Indian J Exp Biol 47 2009 469 474
26. R. Sharma, D. Saxena, A.K. Dwivedi, and A. Misra Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis Pharm Res 18 2001 1405 1410
27. I.M. Orme, and A.M. Cooper Cytokine/chemokine cascades in immunity to tuberculosis Immunol Today 20 1999 307 312
28. I.M. Orme, E.S. Miller, A.D. Roberts, S.K. Furney, J.P. Griffin, and K.M. Dobos T lymphocytes mediating protection and cellular cytolysis during the course of mycobacterium tuberculosis infection. Evidence for different kinetics and recognition of a wide spectrum of protein antigens J Immunol 148 1992 189 196
29. I.M. Orme, A.D. Roberts, J.P. Griffin, and J.S. Abrams Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection J Immunol 151 1993 518 525
30. A.M. Caruso, N. Serbina, E. Klein, K. Triebold, B.R. Bloom, and J.L. Flynn Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis J Immunol 162 1999 5407 5416
31. J.L. Flynn, M.M. Goldstein, K.J. Triebold, B. Koller, and B.R. Bloom Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection Proc Natl Acad Sci U S A 89 1992 12013 12017
32. N.V. Serbina, and J.L. Flynn Early emergence of CD8(+) T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice Infect Immun 67 1999 3980 3988
33. J. Turner, and I.M. Orme Identification of altered integrin alpha/beta chain expression on T cells from old mice infected with Mycobacterium tuberculosis Exp Gerontol 37 2002 907 916
34. W.H. Boom, K.A. Chervenak, M.A. Mincek, and J.J. Ellner Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis Infect Immun 60 1992 3480 3488
35. C.D. D'Souza An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis J Immunol 158 1997 1217 1221
36. A.P. Junqueira-Kipnis, A. Kipnis, A. Jamieson, M.G. Juarrero, A. Diefenbach, and D.H. Raulet NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection J Immunol 171 2003 6039 6045
37. A.M. Cooper, J. Magram, J. Ferrante, and I.M. Orme Mice lacking bioactive IL-12 can generate protective, antigen-speciifc cellular responses to mycobacterial infection only if the IL-12 p40 subunit is present J Immunol 186 2002 1322 1327
38. A.M. Cooper, J. Magram, J. Ferrante, and I.M. Orme IL-12 is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis J Exp Med 186 1997 39 46
39. A.M. Cooper, and J.L. Flynn The protective immune response to Mycobacterium tuberculosis Curr Opin Immunol 7 1995 512 516
40. S.A. Khader, G.K. Bell, J.E. Pearl, J.J. Fountain, J. Rangel-Moreno, and G.E. Cilley IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge Nat Immunol 8 2007 369 377
41. S.A. Khader IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-{gamma} responses if IL-12p70 is available J Immunol 175 2005 788 795
42. S.A. Khader, J.E. Pearl, K. Sakamoto, L. Gilmartin, G.K. Bell, and D.M. Jelley-Gibbs Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice Immunity 2 1995 561 572
43. I.R. Humphreys, G.R. Stewart, D.J. Turner, J. Patel, D. Karamanou, and R.J. Snelgrove A role for dendritic cells in the dissemination of mycobacterial infection Microbes Infect 8 2006 1339 1346
44. A.M. Cooper Cell-mediated immune responses in tuberculosis Annu Rev Immunol 27 2009 393 422
45. D. Ordway, M. Henao-Tamayo, I.M. Orme, and M. Gonzalez-Juarrero Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNFreceptor-associated factor family J Immunol 175 2005 3873 3881
46. M. Gonzalez-Juarrero, and I.M. Orme Characterization of murine lung dendritic cells infected with Mycobacterium tuberculosis Infect Immun 69 2001 1127 1133
47. J. Turner, A.A. Frank, J.V. Brooks, M. Gonzalez-Juarrero, and I.M. Orme The progression of chronic tuberculosis in the mouse does not require the participation of B lymphocytes or interleukin-4 Exp Gerontol 36 2001 537 545
48. M. Gonzalez-Juarrero, L.C. Kingry, D.J. Ordway, M. Henao-Tamayo, M. Harton, and R.J. Basaraba Immune response to mycobacterium tuberculosis and identification of molecular markers of disease Am J Respir Cell Mol Biol 40 2009 398 409
49. V.P. Mohan, C.A. Scanga, K. Yu, H.M. Scott, K.E. Tanaka, and E. Tsang Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology Infect Immun 69 2001 1847 1855
50. M.P. Moiton, C. Richez, C. Dumoulin, N. Mehsen, J. Dehais, and T. Schaeverbeke Role of anti-tumour necrosis factor-alpha therapeutic agents in the emergence of infections Clin Microbiol Infect 12 2006 1151 1153
51. J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, and W.D. Schwieterman Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
52. D.M. Higgins, J. Sanchez-Campillo, A.G. Rosas-Taraco, E.J. Lee, I.M. Orme, and M. Gonzalez-Juarrero Lack of IL-10 alters inflammatory and immune responses during pulmonary Mycobacterium tuberculosis infection Tuberculosis (Edinb) 89 2009 149 157
53. E.F. Redente, D.M. Higgins, L.D. Dwyer-Nield, I.M. Orme, M. Gonzalez-Juarrero, and A.M. Malkinson Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation J Leukoc Biol 88 2010 159 168
54. D. Ordway, D.M. Higgins, J. Sanchez-Campillo, J.S. Spencer, M. Henao-Tamayo, and M. Harton XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability J Leukoc Biol 82 2007 1221 1229
55. A.G. Rosas-Taraco, D.M. Higgins, J. Sanchez-Campillo, E.J. Lee, I.M. Orme, and M.I. Gonzalez-Juarrero Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis Am J Respir Cell Mol Biol 41 2009 136 145
56. M. Bivas-Benita, M.Y. Lin, S.M. Bal, K.E. van Meijgaarden, K.L. Franken, and A.H. Friggen Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice Vaccine 27 2009 4010 4017
57. P.B. Fourie, W.A. Germishuizen, Y.L. Wong, and D.A. Edwards Spray drying TB vaccines for pulmonary administration Expert Opin Biol Ther 8 2008 857 863
58. L. Garcia-Contreras, J. Fiegel, M.J. Telko, K. Elbert, A. Hawi, and M. Thomas Inhaled large porous particles of capreomycin for treatment of tuberculosis in a guinea pig model Antimicrob Agents Chemother 51 2007 2830 2836
59. L. Garcia-Contreras, Y.-L. Wong, P. Muttil, D. Padilla, J. Sadoff, and J. DeRousse Immunization by a bacterial aerosol Proc Natl Acad Sci U S A 105 2008 4656 4660
60. T.H. Jin, E. Tsao, J. Goudsmit, V. Dheenadhayalan, and J. Sadoff Stabilizing formulations for inhalable powders of an adenovirus 35-vectored tuberculosis (TB) vaccine (AERAS-402) Vaccine 28 2010 4369 4375
61. C. Wang, and A. Hickey Isoxyl aerosols for tuberculosis treatment: preparation and characterization of particles AAPS PharmSciTech 11 2010 538 549
62. M. Bivas-Benita, K.E. van Meijgaarden, K.L.M.C. Franken, H.E. Junginger, G. Borchard, and T.H.M. Ottenhoff Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding hla-a0201-restricted T-cell epitopes of Mycobacterium tuberculosis Vaccine 22 2004 1609 1615
63. D.G. Russell, P.-J. Cardona, M.-J. Kim, S. Allain, and F. Altare Foamy macrophages and the progression of the human tuberculosis granuloma Nat Immunol 10 2009 943 948
64. D. Ordway, M. Harton, M. Henao-Tamayo, R. Montoya, I.M. Orme, and M. Gonzalez-Juarrero Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis J Immunol 176 2006 4931 4939
65. Cáceres N., G. Tapia, I. Ojanguren, F. Altare, O. Gil, and S. Pinto Evolution of foamy macrophages in the pulmonary granulomas of experimental tuberculosis models Tuberculosis 89 2009 175 182
66. P. Peyron, J. Vaubourgeix, Y. Poquet, F. Levillain, C. Botanch, and F. Bardou Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. Tuberculosis persistence PLoS Pathog 4 2008 e1000204
67. D.G. Russell Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5 2007 39 47
68. M.J. Kim, H.C. Wainwright, M. Locketz, L.G. Bekker, G.B. Walther, and C. Dittrich Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism EMBO Mol Med 2010
69. E.R. Rhoades, R.E. Geisel, B.A. Butcher, S. McDonough, and D.G. Russell Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components Tuberculosis (Edinb) 85 2005 159 176
70. H. Takimoto, H. Maruyama, K.I. Shimada, Yakabe R., I. Yano, and Y. Kumazawa Interferon-gamma independent formation of pulmonary granuloma in mice by injections with trehalose dimycolate (cord factor), lipoarabinomannan and phosphatidylinositol mannosides isolated from Mycobacterium tuberculosis Clin Exp Immunol 144 2006 134 141
71. L.E. Via, P.L. Lin, S.M. Ray, J. Carrillo, S.S. Allen, and S.Y. Eum Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates Infect Immun 76 2008 2333 2340
72. M.C. Tsai, S. Chakravarty, G. Zhu, J. Xu, K. Tanaka, and C. Koch Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension Cell Microbiol 8 2006 218 232
73. J.L. Flynn, S.V. Capuano, D. Croix, S. Pawar, A. Myers, and A. Zinovik Non-human primates: a model for tuberculosis research Tuberculosis (Edinb) 83 2003 116 118
74. R.J. Basaraba, E.E. Smith, C.A. Shanley, and I.M. Orme Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol Infect Immun 74 2006 5397 5401
75. L.S. Schlesinger, T.M. Kaufman, S. Iyer, S.R. Hull, and L.K. Marchiando Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macrophages J Immunol 157 1996 4568 4575
76. J.B. Torrelles, A.K. Azad, and L.S. Schlesinger Fine discrimination in the recognition of individual species of phosphatidyl-myo-inositol mannosides from Mycobacterium tuberculosis by C-type lectin pattern recognition receptors J Immunol 177 2006 1805 1816
77. J.B. Torrelles, L.E. DesJardin, J. MacNeil, T.M. Kaufman, B. Kutzbach, and R. Knaup Inactivation of Mycobacterium tuberculosis mannosyltransferase PIMb reduces the cell wall lipoarabinomannan and lipomannan content and increases the rate of bacterial-induced human macrophage cell death Glycobiology 19 2009 743 755
78. J.B. Torrelles, and L.S. Schlesinger Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host Tuberculosis (Edinb) 90 2010 84 93
79. J. Nigou, C. Zelle-Rieser, M. Gilleron, M. Thurnher, and G. Puzo Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor J Immunol 166 2001 7477 7485
80. J. Chan, X.D. Fan, S.W. Hunter, P.J. Brennan, and B.R. Bloom Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages Infect Immun 59 1991 1755 1761
81. K.E. Dahl, H. Shiratsuchi, B.D. Hamilton, J.J. Ellner, and Z. Toossi Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis Infect Immun 64 1996 399 405
82. M. Rojas, L.F. Barrera, G. Puzo, and L.F. Garcia Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products J Immunol 159 1997 1352 1361
83. J. Nigou, M. Gilleron, M. Rojas, L.F. Garcia, M. Thurnher, and G. Puzo Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response Microbes Infect 4 2002 945 953
84. N. Dulphy, J.L. Herrmann, J. Nigou, D. Rea, N. Boissel, and G. Puzo Intermediate maturation of Mycobacterium tuberculosis LAM-activated human dendritic cells Cell Microbiol 9 2007 1412 1425
85. V. Briken, S.A. Porcelli, G.S. Besra, and L. Kremer Mycobacterial lipoarabinomannan and related lipoglycans: from biogenesis to modulation of the immune response Mol Microbiol 53 2004 391 403
86. W.L. Beatty, E.R. Rhoades, H.-J. Ullrich, D. Chatterjee, J.E. Heuser, and D.G. Russell Trafficking and release of mycobacterial lipids from infected macrophages Traffic 1 2000 235 247
87. S. Xu, A. Cooper, S. Sturgill-Koszycki, T. van Heyningen, D. Chatterjee, and I. Orme Intracellular trafficking in Mycobacterium tuberculosis and Mycobacterium avium-infected macrophages J Immunol 153 1994 2568 2578
88. T.B. Geijtenbeek, S.J. Van Vliet, E.A. Koppel, M. Sanchez-Hernandez, C.M. Vandenbroucke-Grauls, and B. Appelmelk Mycobacteria target DC-SIGN to suppress dendritic cell function J Exp Med 197 2003 7 17
89. L. Tailleux, O. Schwartz, J.L. Herrmann, E. Pivert, M. Jackson, and A. Amara DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells J Exp Med 197 2003 121 127
90. P.B. Kang, A.K. Azad, J.B. Torrelles, T.M. Kaufman, A. Beharka, and E. Tibesar The human macrophage mannose receptor directs Mycobacterium tuberculosis lipoarabinomannan-mediated phagosome biogenesis J Exp Med 202 2005 987 999
91. N. Maeda, J. Nigou, J.L. Herrmann, M. Jackson, A. Amara, and P.H. Lagrange The cell surface receptor DC-SIGN discriminates between mycobacterium species through selective recognition of the mannose caps on lipoarabinomannan J Biol Chem 278 2003 5513 5516
92. A. Sinha, A. Singh, V. Satchidanandam, and K. Natarajan Impaired generation of reactive oxygen species during differentiation of dendritic cells (DCs) by Mycobacterium tuberculosis secretory antigen (MTSA) and subsequent activation of MTSA-DCs by mycobacteria results in increased intracellular survival J Immunol 177 2006 468 478
93. D.R. Green, T. Ferguson, L. Zitvogel, and G. Kroemer Immunogenic and tolerogenic cell death Nat Rev Immunol 9 2009 353 363
94. M.B. Torchinsky, J. Garaude, A.P. Martin, and J.M. Blander Innate immune recognition of infected apoptotic cells directs T(h)17 cell differentiation Nature 458 2009 78 82
95. M. Oddo, T. Renno, A. Attinger, T. Bakker, H.R. MacDonald, and P.R. Meylan Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis J Immunol 160 1998 5448 5454
96. H. Pan, B.S. Yan, M. Rojas, Y.V. Shebzukhov, H. Zhou, and L. Kobzik Ipr1 gene mediates innate immunity to tuberculosis Nature 434 2005 767 772
97. U.E. Schaible, F. Winau, P.A. Sieling, K. Fischer, H.L. Collins, and K. Hagens Apoptosis facilitates antigen presentation to T lymphocytes through MHC-I and CD1 in tuberculosis Nat Med 9 2003 1039 1046
98. F. Winau, S. Weber, S. Sad, J. de Diego, S.L. Hoops, and B. Breiden Apoptotic vesicles cross prime CD8 T cells and protect against tuberculosis Immunity 24 2006 105 117
99. M. Chen, H. Gan, and H.G. Remold A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis J Immunol 176 2006 3707 3716
100. M. Divangahi, M. Chen, H. Gan, D. Desjardins, T.T. Hickman, and D.M. Lee Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair Nat Immunol 10 2009 899 906
101. H. Gan, J. Lee, F. Ren, M. Chen, H. Kornfeld, and H.G. Remold Mycobacterium tuberculosis blocks crosslinking of annexin-1 and apoptotic envelope formation on infected macrophages to maintain virulence Nat Immunol 9 2008 1189 1197
102. J. Keane, H.G. Remold, and H. Kornfeld Virulent Mycobacterium tuberculosis strains evade apoptosis of infected alveolar macrophages J Immunol 164 2000 2016 2020
103. K. Velmurugan, B. Chen, J.L. Miller, S. Azogue, S. Gurses, and T. Hsu Mycobacterium tuberculosis nuog is a virulence gene that inhibits apoptosis of infected host cells PLoS Pathog 3 2007 e110
104. D. Jayakumar, W.R. Jacobs Jr., and S. Narayanan Protein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infection Cell Microbiol 10 2008 365 374
105. S. Kurtz, K.P. McKinnon, M.S. Runge, J.P. Ting, and M. Braunstein The SecA2 secretion factor of Mycobacterium tuberculosis promotes growth in macrophages and inhibits the host immune response Infect Immun 74 2006 6855 6864
106. J. Hinchey, S. Lee, B.Y. Jeon, R.J. Basaraba, M.M. Venkataswamy, and B. Chen Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis J Clin Invest 117 2007 2279 2288
107. V. Briken, and J.L. Miller Living on the edge: inhibition of host cell apoptosis by Mycobacterium tuberculosis Future Microbiol 3 2008 415 422
108. M. Kundu, S.K. Pathak, K. Kumawat, S. Basu, G. Chatterjee, and S. Pathak A TNF- and C-cbl-dependent FLIP(s)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis Nat Immunol 10 2009 918 926
109. M.K. Balcewicz-Sablinska, J. Keane, H. Kornfeld, and H.G. Remold Pathogenic mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha J Immunol 161 1998 2636 2641
110. J.L. Miller, K. Velmurugan, M.J. Cowan, and V. Briken The type I NADH dehydrogenase of Mycobacterium tuberculosis counters phagosomal NOX2 activity to inhibit TNF-alpha-mediated host cell apoptosis PLoS Pathog 6 2010 e1000864
111. R. Dhiman, M. Raje, and S. Majumdar Differential expression of NF-kappa B in mycobacteria infected THP-1 affects apoptosis Biochim Biophys Acta 1770 2007 649 658
112. L.M. Sly, S.M. Hingley-Wilson, N.E. Reiner, and W.R. McMaster Survival of Mycobacterium tuberculosis in host macrophages involves resistance to apoptosis dependent upon induction of antiapoptotic bcl-2 family member mcl-1 J Immunol 170 2003 430 437
113. J. Lee, H.G. Remold, M.H. Ieong, and H. Kornfeld Macrophage apoptosis in response to high intracellular burden of Mycobacterium tuberculosis is mediated by a novel caspase-independent pathway J Immunol 176 2006 4267 4274
114. M.P. O'Sullivan, S. O'Leary, D.M. Kelly, and J. Keane A caspase-independent pathway mediates macrophage cell death in response to Mycobacterium tuberculosis infection Infect Immun 75 2007 1984 1993
115. A.B. Yadav, and A. Misra Enhancement of apoptosis of THP-1 cells infected with Mycobacterium tuberculosis by inhalable microparticles and relevance to bactericidal activity Antimicrob Agents Chemother 51 2007 3740 3742
116. A.B. Yadav, P. Muttil, A.K. Singh, R.K. Verma, M. Mohan, and A.K. Agrawal Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis Tuberculosis (Edinb) 90 2010 188 196